ScholarIQanswers from OpenAlex

Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations

PaperCitations, authors & open-access status

Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations have?

ScholarIQcitation count

Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations has 21 citations in the OpenAlex counts ScholarIQ stores.

When was Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations published?

ScholarIQyear

Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations has 2022 year in the ScholarIQ index.

What is the open-access status of Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations?

ScholarIQoa status

Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations has diamond oa status in the ScholarIQ index.

What is the DOI of Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations?

ScholarIQdoi

The DOI for Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations is on the source record.

What is the PMID of Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations?

ScholarIQpmid

The PMID for Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations is on the source record.

What is the OpenAlex record for Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations?

ScholarIQopenalex

The OpenAlex for Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial